Cisplatin-based chemoradiation has been shown to be superior to radiotherapy plus hydroxyurea for stage IB to III cervical cancer, conferring better survival rates withmodest long-term toxicity.
Cisplatin-based chemoradiation has been shown to be superior to radiotherapy plus hydroxyurea for stage IB to III cervical cancer, conferring better survival rates withmodest long-term toxicity.
Leave a Reply